New study aims to catch hidden liver disease in diabetes patients
NCT ID NCT07270822
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test a two-step screening program for advanced liver fibrosis in people with type 2 diabetes. About 1,714 patients will first get a blood test (FIB-4), and if that suggests risk, they will receive a liver stiffness measurement (transient elastography). The goal is to see if this systematic approach helps more patients get diagnosed and referred to specialists, compared to current practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could establish a practical screening pathway that catches liver fibrosis earlier in people with type 2 diabetes, potentially reducing liver-related complications.
- What could go wrong
- This is an implementation study, not a treatment trial. It tests whether a screening process works in real-world clinics, not whether it improves health outcomes directly. Success depends on clinic participation and follow-through.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROSIS OF LIVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Diabetology private center
Caluire-et-Cuire, 69300, France
-
Diabetology private center
Lyon, 69001, France
-
Diabetology private center
Lyon, 69001, France
-
Diabetology private center
Lyon, 69002, France
-
Diabetology private center
Lyon, 69005, France
-
Diabetology private center
Lyon, 69009, France
-
Diabetology private center
Lyon, 69009, France
-
Diabetology private center
Lyon, 69009, France
-
Diabetology private center
Saint-Maurice-l'Exil, 38550, France
-
Diabetology private center
Sathonay-Camp, 69580, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a probiotic supplement help reverse fatty liver?
- Simple blood test may spot hidden liver trouble in colitis patients
- Thousands with fatty liver disease monitored to understand long-term risks
- AI spots hidden liver disease in routine scans
- 10,000 seniors studied to predict fatty liver dangers
- New drug tested in patients with fatty liver and cirrhosis